MWAM
BSX icon

Manhattan West Asset Management’s Boston Scientific BSX Stock Holding History

Manhattan West Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,121
Closed -$202K – 150
2025
Q4 		$202K Sell
2,121
-50
-2% -$4.9K 0.04% 140
2025
Q3 		$212K Sell
2,171
-131
-6% -$13.6K 0.04% 137
2025
Q2 		$247K Buy
2,302
+176
+8% +$17.8K 0.06% 125
2025
Q1 		$214K Buy
+2,126
New +$214K 0.05% 133

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Manhattan West Asset Management's BSX Position: Q1 2026 in Review

Manhattan West Asset Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,121 shares — an estimated $202K sold.

Manhattan West Asset Management first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $247K in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Manhattan West Asset Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Manhattan West Asset Management sold 2,121 Boston Scientific shares in Q1 2026, an estimated $202K.
  • Manhattan West Asset Management first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • Manhattan West Asset Management's Boston Scientific position peaked at $247K in Q2 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Manhattan West Asset Management's 13F filing for Q1 2026, filed 14 May 2026.